Page last updated: 2024-12-07

triptycene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Triptycene is a polycyclic aromatic hydrocarbon consisting of three benzene rings bridged by three methylene groups. It is a rigid and symmetrical molecule with a propeller-like structure. It was first synthesized in 1942 by P. D. Bartlett and W. S. Johnson. Triptycene has been extensively studied for its unique structural and electronic properties, which have led to its applications in various fields, including organic electronics, molecular machines, and supramolecular chemistry. The synthesis of triptycene typically involves a Diels-Alder reaction between anthracene and a suitable dienophile, such as a benzyne derivative. Triptycene's rigid structure and its ability to accommodate multiple substituents make it an ideal building block for the construction of complex molecules. Its electronic properties have also made it attractive for use in organic electronics, where it has been incorporated into organic field-effect transistors, organic light-emitting diodes, and other devices. The unique structure of triptycene has also led to its use as a component in molecular machines, where its ability to rotate and interact with other molecules has been exploited to create devices with nanoscale motion. Due to its unique properties and applications, triptycene remains a subject of active research in organic chemistry and materials science.'

triptycene: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID92764
CHEBI ID188520
MeSH IDM0510949

Synonyms (50)

Synonym
9,10-dihydro-9,10-o-benzenoanthracene
triptycene
477-75-8
nsc-122926
9,2']-benzenoanthracene, 9,10-dihydro-
tryptycene
tribenzobicyclo[2.2.2]octatriene
nsc122926
9,10[1',2']-benzenoanthracene, 9,10-dihydro-
pentacyclo[6.6.6.0~2,7~.0~9,14~.0~15,20~]icosa-2,4,6,9,11,13,15,17,19-nonaene
AH-357/31481008
triptycene, 98%
pentacyclo[6.6.6.02,7.09,14.015,20]icosa-2,4,6,9,11,13,15,17,19-nonaene
CHEBI:188520
AKOS004901795
T2807
9,10-dihydro-9,10-[1,2]benzenoanthracene
nsc 122926
einecs 207-519-3
9,10-o-benzeno-9,10-dihydroanthracene
cl32869mep ,
9,10-o-benzenoanthracene, 9,10-dihydro-
unii-cl32869mep
9,10(1',2')-benzenoanthracene, 9,10-dihydro-
tribenzobicyclo(2.2.2)octatriene
FT-0688191
tripycene
DTXSID6060058
triptycene [mi]
9,10-dihydro-9,10-(1,2)-benzenoanthracene
NGDCLPXRKSWRPY-UHFFFAOYSA-N
anthracene, 9,10-dihydro-9,10-o-benzeno-
mfcd00003813
triptycene;triptycene
52776-05-3
BBL103025
pentacyclo[6.6.6.0~2,7~.0~9,14~.0~15,20~]icosa-2,4,6,9,11,13,15,17,19-nonaene (non-preferred name)
STL556834
Q411264
SY049545
9,10[1',2']-benzenoanthracene,9,10-dihydro-
AS-17890
AMY15439
boc-d-asparticacida-benzylester
SY252774
YSWG054
9,10-o-benzenoanthracene, 9,10-dihydro-;9,10-dihydro-9,10-[1,2]benzenoanthracene
A846973
F14824
CS-W018422

Research Excerpts

Effects

ExcerptReferenceRelevance
"Triptycenes have been shown to bind nucleic acid three-way junctions, but rapid and efficient methods to diversify the triptycene core are lacking. "( Synthesis of 9-Substituted Triptycene Building Blocks for Solid-Phase Diversification and Nucleic Acid Junction Targeting.
Barros, SA; Chenoweth, DM; Suh, SE; Yoon, I, 2016
)
2.17
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
anthracenesCompounds containing an anthracene skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (45)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.22)18.7374
1990's0 (0.00)18.2507
2000's6 (13.33)29.6817
2010's26 (57.78)24.3611
2020's12 (26.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.98

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.98 (24.57)
Research Supply Index3.83 (2.92)
Research Growth Index5.05 (4.65)
Search Engine Demand Index54.33 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.98)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.22%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other44 (97.78%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]